Evidence map›Paper›PMID 41067280›Full record

ArticleThe Journal of allergy and clinical immunology2026

Effects of type 3 and neutrophilic inflammation on type 2 chronic rhinosinusitis with nasal polyps.

Aiko Oka, Aiko I Klingler, Masanori Kidoguchi, Julie A Poposki, Lydia A Suh, Junqin Bai, Whitney W Stevens, Anju T Peters, Leslie C Grammer, Kevin C Welch and 11 more

Abstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Aiko OkaDivision of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill.
Aiko I KlinglerDivision of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill.
Masanori KidoguchiDivision of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill.
Julie A PoposkiDivision of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill.
Lydia A SuhDivision of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill.
Junqin BaiDepartment of Otolaryngology-Head & Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, Ill.
Whitney W StevensDivision of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill.
Anju T PetersDivision of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill.
Leslie C GrammerDivision of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill.
Kevin C WelchDepartment of Otolaryngology-Head & Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, Ill.
Stephanie S SmithDepartment of Otolaryngology-Head & Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, Ill.
David B ConleyDepartment of Otolaryngology-Head & Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, Ill.
Brian S SchwartzDepartment of Environmental Health and Engineering, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Md.
Micah JohnsonRegeneron Pharmaceuticals, Inc, Tarrytown, NY.
Amr RadwanRegeneron Pharmaceuticals, Inc, Tarrytown, NY.
Robert P SchleimerDivision of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill; Department of Otolaryngology-Head & Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, Ill.
Robert C KernDivision of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill; Department of Otolaryngology-Head & Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, Ill.
Bruce K TanDepartment of Otolaryngology-Head & Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, Ill.
Shigeharu FujiedaDepartment of Otolaryngology, Head and Neck Surgery, Fukui University, Yoshida-gun, Fukui, Japan.
Mitsuhiro OkanoDepartment of Otolaryngology, International University of Health and Welfare, Narita, Chiba, Japan.
Atsushi KatoDivision of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill; Department of Otolaryngology-Head & Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, Ill. Electronic address: a-kato@northwestern.edu.

Funding

Population-based CRS epidemiology: sex differences, natural history, and long-term outcomes based on clinically-defined phenotypes and biologically-based endotypes - GeisingerP01AI145818 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KATO, ATSUSHI · 2019 to 2023
$9.3M
Systems Genetics Approach to Gene Discovery in Chronic RhinosinusitisU19AI106683 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KERN, ROBERT C · 2014 to 2017
$7.9M
Initiators, biomarkers and mechanisms of epithelial dysfunction and immune pathogenesis in chronic rhinosinusitis and aspirin exacerbated respiratory disease (AERD)R01AI137174 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SCHLEIMER, ROBERT P · 2018 to 2022
$3.1M
NIAID NIH HHS P01 AI145818NIAID NIH HHS R01 AI137174NIAID NIH HHS U19 AI106683
6 · The paper itself

Abstract

backgroundChronic rhinosinusitis with nasal polyps (CRSwNP) is most commonly divided into 3 endotypes (type 1 [T1], T2, and T3) on the basis of the T-cell cytokine profiles. Although neutrophils are classically associated with T3 inflammation in chronic rhinosinusitis, neutrophilic infiltration can be present without a T3 signal.

objectiveWe sought to identify the effects of T3 and neutrophilic (called neutrophil variant or Vneut) inflammation on clinical presentations and phenotype-associated mechanisms in patients with T2 CRSwNP.

methodsWe obtained 66 control ethmoid tissues and 158 nasal polyps (NPs). We measured mRNA markers for T1, T2, T3, and Vneut inflammation by quantitative RT-PCR and whole RNA expression profiles by bulk RNA sequencing. We investigated associations between the endotypes and natural histories and predicted molecular pathways by gene enrichment analysis.

resultsBecause 96% of the NPs had T2 endotype, most T1, T3, and Vneut inflammation coexisted with T2 endotype. Recurrent NP was associated with mixed T2 + T3 (P = .012) as well as T2 + Vneut (P = .022) inflammation, whereas sinus computed tomography and NP scores were associated only with T2 + Vneut inflammation (P < .05). Compared with control tissues, we identified shared and specific dysregulated genes in T2 single, T2 + T3, and T2 + Vneut mixed endotypes, and the results suggest that NP recurrence (T2 + T3 and T2 + Vneut shared dysregulated genes) was associated with activation of cytotoxic T cells and M1 macrophages, whereas sinus computed tomography and NP scores (T2 + Vneut-specific genes) were associated with activation of neutrophils, M2 macrophages, and fibroblasts as well as with downregulation of innate host defense.

conclusionsT3 and neutrophilic inflammation induce different molecular pathways resulting in distinct clinical presentations in T2 CRSwNP.

Indexed as

InflammationNasal PolypsNeutrophilsRhinitisSinusitisAdultAgedChronic DiseaseFemaleHumansMaleMiddle AgedRhinosinusitischronic rhinosinusitisLund-Mackay CT scorenasal polypsNeutrophilspolyp recurrenceRNA sequencingT(H)17

Identifiers

PMID41067280
PMCPMC12594462

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.